+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Radiosensitization by cisplatin of rif 1 tumor cells in vitro

International Journal of Radiation Biology & Related Studies in Physics Chemistry & Medicine 50(5): 871-884

Radiosensitization by cisplatin of rif 1 tumor cells in vitro

The ability of cis-diamminedichoroplatinum(II) (c-DDP) to enhance radiation-induced cell killing was tested on oxic RIF1 tumour cells in monolayer culture. Marked radiosensitization of the survivors of a 1 h drug treatment was found with all c-DDP doses treated, with enhancement ratios increasing from 1.2 to 2.2 with increasing drug dose. Isobologram analyses showed that the interaction of c-DDP with X-rays were supra-additive. To test whether part of the enhancement was due to a selection of subpopulations, the diploid and tetraploid RIF1 cells, which normally coexist in culture, were separated by (a) unit gravity velocity sedimentation, and (b) by developing diploid and tetraploid clones. Both methods showed that there was little difference in either drug sensitivity or radiation sensitivity between diploid and tetraploid cells. DNA histograms obtained by flow cytometry showed little or no cycle progression during the 1 h drug treatment. These data indicate that the radiosensitization was not the result of the drug exposure leaving cells in a radiosensitive phase. The observed radiosensitization, therefore, appears to have resulted from a true drug/X-ray interaction.

(PDF 0-2 workdays service: $29.90)

Accession: 006255093

PMID: 3490450

Related references

Radiosensitization of LPB fibrosarcoma mouse tumor model by electroporation with cisplatin, in vitro and in vivo. Anticancer Research 22(6C): 4306-4307, November-December, 2002

Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiation Research. 133(2): 252-256, 1993

Radiosensitization of human tumor cells by gemcitabine in vitro. Seminars in Oncology 22(4 Suppl 11): 68-71, 1995

A study of Cisplatin-radiosensitization through inhibition of repair of sublethal radiation-damage in ovarian-carcinoma cells sensitive and resistant to Cisplatin. International Journal of Oncology 7(6): 1373-1378, 1995

Radiosensitization of hypoxic tumor cells in vitro by nitric oxide. International Journal of Radiation Oncology Biology Physics 36(2): 377-383, 1996

Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. Journal of Cancer Research and Therapeutics 5 Suppl 1: S27-S31, 2010

Radiosensitization by the combination of SR-2508 and paclitaxel in hypoxic human tumor cells in vitro. Journal of Radiation Research 48(3): 179-185, 2007

Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. RadioTherapy and Oncology 74(2): 117-129, 2005

Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia. Plos One 9(10): E111199-E111199, 2016

Radiosensitization of FM3A cells by 5-fluorouracil plus cisplatin. Acta Medica et Biologica 44(3): 141-145, 1996